نتایج جستجو برای: srl peptide

تعداد نتایج: 160137  

2009
Junhui Li Guodong Zhou Hai Zhao Qiaoming Zhu Peide Qian

This paper explores Chinese semantic role labeling (SRL) for nominal predicates. Besides those widely used features in verbal SRL, various nominal SRL-specific features are first included. Then, we improve the performance of nominal SRL by integrating useful features derived from a state-of-the-art verbal SRL system. Finally, we address the issue of automatic predicate recognition, which is ess...

ساطع, حسین, سدادی, فرشته, صدقی‌پور, محسن, طباطبایی, سید عبدالحسین, قربانی یکتا, بتول, نیک‌دوست, فرحناز, کمال هدایت, داریوش,

Background: Persistence of left ventricular hypertrophy (LVH) in renal transplant recipients is associated with unfavorable outcomes. Calcineurin-inhibitor (CNI) nephrotoxicity is a major cause of morbidity and mortality after kidney transplantation. In this study we compared sirolimus (SRL) with calcineurin-inhibitor as primary immunosuppressants for the attenuation of left ventricular hypertr...

Journal: :Revista medica de Chile 2008
Jorge Roque E Gloria Ríos M Paulina Vignolo A Constanza Pinochet V Marcela Schultz Roberto Humeres A Angela Delucchi Montserrat Rius A Juan Hepp K

BACKGROUND Sirolimus (SRL) is an immunosuppressive drug increasingly used in children undergoing solid organ transplantation. SRL does not cause glucose intolerance, hypertension, nephrotoxicity or neurotoxicity offering significant potential advantages over calceneurin inhibitors (CM). AIM To report five children treated with SRL. MATERIAL AND METHODS A retrospective review of four childre...

2016
Ji Hyun Yu Kyoung Woon Kim Bo-Mi Kim Byung Ha Chung Mi-La Cho Bum Soon Choi Cheol Whee Park Yong-Soo Kim Chul Woo Yang

BACKGROUND/AIMS Sirolimus (SRL) is a promising immunosuppressant replacingcalcineurin inhibitors (CNIs). This study was performed to evaluate the safetyand immunologic benefits of conversion to SRL in stable kidney transplant (KT)recipients exposed to CNIs for long periods. METHODS Fourteen CNI-treated KT recipients with stable renal function for morethan 10 years were included. Either 2 or 3...

2012
Jin Young Kim Jung Yeon Ghee Sun Woo Lim Shang Guo Piao Byung Ha Chung Hye Eun Yoon Hyeon Seok Hwang Bum Soon Choi Jin Kim Chul Woo Yang

Sirolimus (SRL) is a promising drug for replacing calcineurin inhibitors. We performed this study to determine the optimal time of conversion from cyclosporine (CsA) to SRL in an experimental model of chronic CsA nephropathy. Three separate studies were performed. In the first study, SRL was given to rats with or without CsA for 4 weeks. In the second study, rats were treated initially with CsA...

2017
Nora M. Foerst Julia Klug Gregor Jöstl Christiane Spiel Barbara Schober

University students are supposed to be autonomous learners, able to adapt to an educational environment significantly less guided than school. Entering higher education poses a challenge of self-regulation, in which beginning students are often not prepared with self-regulation strategies needed. Since there are many studies assessing self-regulated learning (SRL) via classical self-reports, we...

Journal: :Circulation 2001
T Suzuki G Kopia S Hayashi L R Bailey G Llanos R Wilensky B D Klugherz G Papandreou P Narayan M B Leon A C Yeung F Tio P S Tsao R Falotico A J Carter

BACKGROUND The purpose of this study was to determine the efficacy of stent-based delivery of sirolimus (SRL) alone or in combination with dexamethasone (DEX) to reduce in-stent neointimal hyperplasia. SRL is a potent immunosuppressive agent that inhibits SMC proliferation by blocking cell cycle progression. METHODS AND RESULTS Stents were coated with a nonerodable polymer containing 185 micr...

2013
Sandra Müller-Krebs Lena Weber Julia Tsobaneli Lars P. Kihm Jochen Reiser Martin Zeier Vedat Schwenger

Everolimus (EVL) and Sirolimus (SRL) are potent immunosuppressant agents belonging to the group of mammalian target of rapamycin (mTOR) inhibitors used to prevent transplant rejection. However, some patients develop proteinuria following a switch from a calcineurin inhibitor regimen to mTOR inhibitors. Whether different mTOR inhibitors show similar effects on podocytes is still unknown. To anal...

Journal: :Journal of the American Society of Nephrology : JASN 2004
Henri Kreis Rainer Oberbauer Josep M Campistol Timothy Mathew Pierre Daloze Francesco P Schena James T Burke Yves Brault Martine Gioud-Paquet Joseph A Scarola John F Neylan

Graft function at 6 or 12 mo is positively correlated with renal transplant survival. The 36-mo results of a study that tested whether withdrawing cyclosporine (CsA) from a sirolimus (SRL)-CsA-steroid (ST) regimen would affect renal graft survival are reported. Eligible patients (n = 430) who were receiving SRL-CsA-ST were randomly assigned at 3 mo to remain on SRL-CsA-ST or to have CsA withdra...

Journal: :Circulation 2003
Camille Dambrin Jochen Klupp Tudor Bîrsan Jorge Luna Takeshi Suzuki Tuan Lam Peter Stähr Bernard Hausen Uwe Christians Peter Fitzgerald Gerald Berry Randall Morris

BACKGROUND Delayed treatment with sirolimus (SRL) halts progression of graft vascular disease (GVD) in nonhuman primate (NHP) aortic allograft recipients. In this study, we investigated whether SRL monotherapy prevents the development of GVD. METHODS AND RESULTS Pairs of 3-cm infrarenal aortic segments were exchanged between mixed lymphocyte reaction-mismatched, blood group-compatible NHPs (n...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید